Mehra Golshan Selected Research

Mehra Golshan Research Topics

Disease

49	Breast Neoplasms (Breast Cancer) 03/2022 - 07/2006
41	Neoplasms (Cancer) 03/2022 - 07/2006
10	Pathologic Complete Response 01/2022 - 05/2013
10	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2021 - 01/2008
9	Triple Negative Breast Neoplasms 01/2022 - 01/2015
4	Pain (Aches) 09/2021 - 12/2016
3	Residual Neoplasm 01/2021 - 10/2014
3	Lymphedema (Milroy Disease) 11/2018 - 03/2003
3	Margins of Excision 12/2015 - 12/2012
2	Neoplasm Micrometastasis 10/2019 - 01/2008
2	Postoperative Pain 01/2019 - 01/2019
2	Inflammatory Breast Neoplasms 09/2017 - 09/2006
2	Neutropenia 12/2016 - 01/2015
2	Necrosis 03/2013 - 02/2011
1	Second Primary Neoplasms (Neoplasms, Second) 03/2022
1	Disease Progression 01/2022
1	Genomic Instability 11/2021
1	Ductal Carcinoma 05/2021
1	COVID-19 08/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Venous Thromboembolism 11/2018
1	Hematoma 11/2018
1	Infections 01/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Hemorrhage 01/2015
1	Thrombocytopenia (Thrombopenia) 01/2015
1	Abscess 11/2014
1	Hidradenitis 11/2014
1	Neoplasm Metastasis (Metastasis) 09/2011
1	Lymphatic Metastasis 07/2010
1	Male Breast Neoplasms (Male Breast Cancer) 12/2007
1	Hypersensitivity (Allergy) 09/2006
1	Anaphylaxis (Anaphylactic Shock) 09/2006
1	Neuroblastoma 08/2006
1	Edema (Dropsy) 03/2003
1	Carcinoma (Carcinomatosis) 03/2003

Drug/Important Bio-Agent (IBA)

12	Hormones (Hormone)IBA 12/2019 - 12/2012
6	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2015
5	human ERBB2 proteinIBA 10/2021 - 05/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2015
4	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2015
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2015
4	Biological ProductsIBA 01/2020 - 12/2012
3	Estrogens (Estrogen)FDA Link 01/2019 - 05/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 05/2013
2	veliparibIBA 11/2021 - 01/2018
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 09/2021 - 09/2019
2	Capecitabine (Xeloda)FDA Link 01/2021 - 04/2014
2	Opioid Analgesics (Opioids)IBA 01/2019 - 01/2019
2	Trastuzumab (Herceptin)FDA Link 05/2013 - 09/2011
1	Messenger RNA (mRNA)IBA 01/2022
1	PlatinumIBA 11/2021
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Phenobarbital (Luminal)FDA Link 10/2021
1	IonsIBA 09/2021
1	4- propionyloxy- 4- phenyl- N- methylpiperidineIBA 09/2021
1	Immune Checkpoint InhibitorsIBA 08/2021
1	Estrogen ReceptorsIBA 05/2021
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	VaccinesIBA 08/2020
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2018
1	antineoplaston A10 (A 10)IBA 09/2017
1	Biological FactorsIBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2016
1	Dihydrotachysterol (AT 10)IBA 04/2016
1	LipidsIBA 10/2014
1	Epidermal Growth Factor (EGF)IBA 12/2012
1	Methylene Blue (Methylthioninium Chloride)FDA Link 09/2006
1	iso-sulfan blue (Lymphazurin)FDA LinkGeneric 09/2006

Therapy/Procedure

24	Neoadjuvant Therapy 01/2022 - 08/2006
24	Therapeutics 01/2022 - 08/2006
19	Mastectomy (Mammectomy) 09/2021 - 01/2008
16	Segmental Mastectomy (Lumpectomy) 09/2021 - 07/2006
10	Radiotherapy 01/2022 - 08/2006
10	Drug Therapy (Chemotherapy) 09/2021 - 08/2006
7	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 03/2003
3	Modified Radical Mastectomy (Mastectomy, Modified) 09/2017 - 08/2006
3	Prophylactic Mastectomy 07/2017 - 11/2015
2	Preoperative Exercise 03/2022 - 09/2019
2	Mammaplasty (Breast Reconstruction) 10/2019 - 02/2011
2	Adjuvant Chemotherapy 01/2019 - 01/2017
1	Conduction Anesthesia (Regional Anesthesia) 09/2021
1	Immunotherapy 08/2021
1	Perioperative Care 01/2019
1	Bariatric Surgery 01/2019
1	Palliative Care (Palliative Therapy) 01/2019
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2019
1	Blood Transfusion (Blood Transfusions) 11/2018
1	Biological Therapy 09/2017
1	Chemoprevention 07/2017
1	Simple Mastectomy 01/2017
1	Patient Positioning 12/2016
1	Withholding Treatment 12/2016
1	Body Piercing (Piercing, Body) 11/2014